Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious disease
Pharma
CorMedix buys Melinta for $300M, adding 7 marketed products
CorMedix is expanding its portfolio of infectious disease products for hospitalized patients with the acquisition of Melinta for $300 million.
Kevin Dunleavy
Aug 7, 2025 11:36am
GSK snags FDA approval for new UTI treatment Blujepa
Mar 25, 2025 2:20pm
Mpox still a risk as new awareness campaigns launch
Aug 10, 2023 10:15am
Pfizer, Gilead, GSK to dominate infectious disease market
Jul 20, 2023 9:45am
Shionogi, Takeda, AbbVie-BeiGene—Fierce Pharma Asia
Jun 30, 2023 9:45am
Bavarian Nordic's mpox vaccine Jynneos up to 86% effective: CDC
May 18, 2023 1:29pm
